AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 285: H1332-H1339, 2003; doi:10.1152/ajpheart.00353.2003
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by K. Jackson, M. F.
Right arrow Articles by Caffrey, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by K. Jackson, M. F.
Right arrow Articles by Caffrey, J. L.

Bimodal {delta}-opioid receptors regulate vagal bradycardia in canine sinoatrial node

M. Farias K. Jackson, D. Yoshishige, and J. L. Caffrey

Department of Integrative Physiology and Cardiovascular Research Institute, University of North Texas Health Science Center, Fort Worth, Texas 76107

Submitted 28 April 2003 ; accepted in final form 16 May 2003

Methionine-enkephalin-arginine-phenylalanine (MEAP) introduced into the interstitium of the canine sinoatrial (SA) node by microdialysis interrupts vagal bradycardia. In contrast, raising endogenous MEAP by occluding the SA node artery improves vagal bradycardia. Both are blocked by the same {delta}-selective antagonist, naltrindole. We tested the hypothesis that vagal responses to intranodal enkephalin are bimodal and that the polarity of the response is both dose- and opioid receptor subtype dependent. Ultralow doses of MEAP were introduced into the canine SA node by microdialysis. Heart rate frequency responses were constructed by stimulating the right vagus nerve at 1, 2, and 3 Hz. Ultralow MEAP infusions produced a 50–100% increase in bradycardia during vagal stimulation. Maximal improvement was observed at a dose rate of 500 fmol/min with an ED50 near 50 fmol/min. Vagal improvement was returned to control when MEAP was combined with the {delta}-antagonist naltrindole. The dose of naltrindole (500 fmol/min) was previously determined as ineffective vs. the vagolytic effect of higher dose MEAP. When MEAP was later reintroduced in the same animals at nanomoles per minute, a clear vagolytic response was observed. The {delta}1-selective antagonist 7-benzylidenenaltrexone (BNTX) reversed the vagal improvement with an ED50 near 1 x 10–21 mol/min, whereas the {delta}2-antagonist naltriben had no effect through 10–9 mol/min. Finally, the improved vagal bradycardia previously associated with nodal artery occlusion and endogenous MEAP was blocked by the selective {delta}1-antagonist BNTX. These data support the hypothesis that opioid effects within the SA node are bimodal in character, that low doses are vagotonic, acting on {delta}1-receptors, and that higher doses are vagolytic, acting on {delta}2-receptors.

heart rate; enkephalins; opiate receptors; microdialysis; parasympathetic nervous system


Address for reprint requests and other correspondence: J. L. Caffrey, Dept. of Integrative Physiology, Univ. of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107 (E-mail: jcaffrey{at}hsc.unt.edu).




This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Repeated Arterial Occlusion, Delta-Opioid Receptor (DOR) Plasticity and Vagal Transmission Within the Sinoatrial Node of the Anesthetized Dog
Experimental Biology and Medicine, January 1, 2009; 234(1): 84 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey
Cholinergic location of {delta}-opioid receptors in canine atria and SA node
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H829 - H838.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Deo, S. Johnson-Davis, M. A. Barlow, D. Yoshishige, and J. L. Caffrey
Repeated {delta}1-opioid receptor stimulation reduces {delta}2-opioid receptor responses in the SA node
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2246 - H2254.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Davis, S. H. Deo, M. Barlow, D. Yoshishige, M. Farias, and J. L. Caffrey
The monosialosyl ganglioside GM-1 reduces the vagolytic efficacy of {delta}2-opioid receptor stimulation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2318 - H2326.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. A. Barlow, S. Deo, S. Johnson, and J. L. Caffrey
Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms.
Experimental Biology and Medicine, April 1, 2006; 231(4): 387 - 395.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Younes, S. Pepe, D. Yoshishige, J. L. Caffrey, and E. G. Lakatta
Ischemic preconditioning increases the bioavailability of cardiac enkephalins
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1652 - H1661.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.